Trial - Protection in the progeny of flocks vaccinated against CAV

Protection of the progeny against chicken anemia virus infection from different vaccinated flocks was estimated by challenge experiments.

Experimental design

  • Day-old chickens, both SPF and commercial chickens, derived from vaccinated breeding stock, were challenged with a Japanese isolate, a Dutch isolate and an isolate from the United States
  • Challenge was done by intramuscular route.
  • Two weeks later blood samples were taken for determination of the haematocrit
  • Also at this stage post-mortem examination of thymus and bone marrow was carried out
  • Protection was assessed by the mortality due to CAV, if the haematocrit value was below 27% or if the thymus atrophy or paleness of the bone-marrow was scored as 1 or 2, according to the score table below. 

Post mortem examination

At post-mortem examination atrophy of the thymus and paleness of the bone-marrow were evaluated according to the following scoring system:

Scoring of thymus and bone marrow at post mortem
0No pathological changes
1Slightly pale bone marrow / slightly atrophy of the thymus
2Pale fatty bone marrow / severe thymus atrophy
Origin of challenged 1 day-old chicks and serological status

Breeding stock vaccinated by:

Log2 VN titre at time of egg collection

Protection

Intramuscular route

11.6±1.0

Yes

Subcutaneous route

10.6±1.5

Yes

Wingweb route

11.3±1.1

Yes

SPF

Negative

No

Conclusion

The progeny from breeding stock with high VN titres against CAV (in this case induced by vaccination with Nobilis CAV P4) at time of egg collection was protected against a virulent challenge with 3 different isolates of CAV

 

chickens